Relx (LON:REL) PT Raised to GBX 2,225 at Credit Suisse Group
Relx (LON:REL) had its price target raised by Credit Suisse Group from GBX 2,065 ($27.16) to GBX 2,225 ($29.27) in a report issued on Monday morning, Stock Target Advisor reports. The brokerage currently has an outperform rating on the stock.
Several other analysts also recently issued reports on REL. HSBC reaffirmed a buy rating on shares of Relx in a report on Monday, January 13th. Barclays upped their price target on shares of Relx from GBX 2,090 ($27.49) to GBX 2,275 ($29.93) and gave the company an overweight rating in a report on Thursday, January 30th. JPMorgan Chase & Co. upped their price target on shares of Relx from GBX 1,950 ($25.65) to GBX 2,250 ($29.60) and gave the company an overweight rating in a report on Friday, February 14th. Liberum Capital reaffirmed a buy rating on shares of Relx in a report on Thursday, February 13th. Finally, Morgan Stanley upped their price target on shares of Relx from GBX 1,830 ($24.07) to GBX 2,250 ($29.60) and gave the company an equal weight rating in a report on Tuesday, January 28th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The stock currently has an average rating of Buy and a consensus target price of GBX 2,043 ($26.87).
Shares of LON REL opened at GBX 2,070 ($27.23) on Monday. Relx has a 12-month low of GBX 1,597 ($21.01) and a 12-month high of GBX 2,100 ($27.62). The company has a market capitalization of $40.27 billion and a PE ratio of 26.85. The company has a debt-to-equity ratio of 308.02, a current ratio of 0.45 and a quick ratio of 0.40. The firm’s 50-day moving average is GBX 2,008.45 and its two-hundred day moving average is GBX 1,911.16.
In other news, insider Erik Engstrom sold 32,368 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of GBX 2,073 ($27.27), for a total value of £670,988.64 ($882,647.51).
Relx Company Profile
RELX PLC provides information based-analytics and decision tools for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals that enables progress in science, advance healthcare, and performance improvement.
Featured Story: Bid-Ask Spread
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.